Vagus Nerve Stimulation for Rosacea
What You Need to Know Before You Apply
What is the purpose of this trial?
A single arm, pilot study among individuals with rosacea and at least moderate flushing or rednesss will be enrolled in a 4-week trial of taVNS. The particicpants will be followed for an additional 4-weeks following the intervention period to evaluate the durability of the results
Are You a Good Fit for This Trial?
This trial is for adults diagnosed with rosacea who have at least moderate redness or flushing. Participants must be willing to stick to their current rosacea treatment plan and not start any new treatments, including laser therapy, during the study.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a 4-week trial of transcutaneous auricular vagus nerve stimulation (taVNS) for rosacea
Follow-up
Participants are monitored for safety and effectiveness after treatment to evaluate the durability of the results
What Are the Treatments Tested in This Trial?
Interventions
- Transaricular vagus nerve stimulation (taVNS)
Trial Overview
The study tests a device called transcutaneous auricular vagus nerve stimulation (taVNS) over 4 weeks in people with rosacea. All participants receive the same treatment and are monitored for another 4 weeks after finishing.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
Brigham and Women's Hospital
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.